To screen for prognostic-associated immune cell subsets, we performed univariate Cox survival analysis and found there was a significant correlation between immune cell abundance and survival rate in luminal B, HER2-enriched and basal-like breast cancer (Figure S3). The gene discussed is ERBB2; the disease is breast carcinoma.